Dupilumab Treatment for Atopic Dermatitis Associated with Reduced Risk of Alopecia Areata: A Multicenter Cohort Study - PubMed
6 hours ago
- #alopecia areata
- #atopic dermatitis
- #dupilumab
- Dupilumab treatment for atopic dermatitis is associated with a reduced risk of developing alopecia areata.
- The study is a multicenter cohort study, indicating a broad, collaborative research effort across multiple institutions.
- Findings suggest that dupilumab, an immunology-focused treatment, may have protective effects against autoimmune conditions like alopecia areata and alopecia universalis.
- The research contributes to understanding the interplay between atopic dermatitis, autoimmune diseases, and targeted treatments in the field of allergy and immunology.